Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “L-DOPA”

104 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 104 results

Post-approval studies (Phase 4)Ended earlyNCT03761030
What this trial is testing

L-DOPA vs. Placebo for Depression and Psychomotor Slowing in Older Adults

Who this might be right for
Major Depressive DisorderDysthymiaDepression
New York State Psychiatric Institute 51
Early research (Phase 1)WithdrawnNCT01500707
What this trial is testing

Single Dose Study to Assess the Pharmacokinetics of SCH 900800 in Subjects With Parkinson's Disease Being Treated With Levodopa (L-DOPA) (P08235)

Who this might be right for
Parkinson's Disease
Merck Sharp & Dohme LLC
Testing effectiveness (Phase 2)Study completedNCT01538329
What this trial is testing

Amantadine and L-DOPA-induced Dyskinesia in Early Parkinson's Disease

Who this might be right for
Parkinson Disease
University Hospital, Toulouse 210
Testing effectiveness (Phase 2)Study completedNCT00224263
What this trial is testing

Efficacy and Safety of Lingzhi in Patients With Early Parkinson's Disease

Who this might be right for
Parkinson's Disease
Xuanwu Hospital, Beijing 360
Large-scale testing (Phase 3)Study completedNCT00466167
What this trial is testing

Pivotal Study in Advanced Parkinsons Disease Patients

Who this might be right for
Parkinson Disease
Boehringer Ingelheim 517
Testing effectiveness (Phase 2)Study completedNCT00013624
What this trial is testing

Riluzole to Treat Parkinson's Disease

Who this might be right for
Parkinson's Disease
National Institute of Neurological Disorders and Stroke (NINDS) 20
Not applicableStudy completedNCT02200887
What this trial is testing

Sleep Homeostasis in Parkinson's Disease

Who this might be right for
Parkinson Disease
Salvatore Galati 48
Testing effectiveness (Phase 2)Ended earlyNCT03250117
What this trial is testing

Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole

Who this might be right for
Parkinson Disease
Titan Pharmaceuticals 6
Large-scale testing (Phase 3)Study completedNCT01154166
What this trial is testing

A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatment With Ropinirole PR as Adjunctive Therapy in Patients With Parkinson's Disease Who Are Not Optimally Controlled on L-Dopa

Who this might be right for
Parkinson Disease
GlaxoSmithKline 347
Large-scale testing (Phase 3)Study completedNCT00363727
What this trial is testing

Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's

Who this might be right for
Parkinson's DiseaseParkinson DiseaseDyskinesias
GlaxoSmithKline 209
Large-scale testing (Phase 3)Temporarily pausedNCT04000919
What this trial is testing

Effects of 5HTP and LDOPA on CNS Excitability After SCI

Who this might be right for
Spinal Cord Injuries
Jessica M D'Amico 30
Not applicableStudy completedNCT03994328
What this trial is testing

An Observational Study on Safinamide, Rasagiline and Other Standard of Care in PD

Who this might be right for
Parkinson's Disease
Zambon SpA 1,235
Testing effectiveness (Phase 2)Study completedNCT01491932
What this trial is testing

Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Who this might be right for
DyskinesiasParkinson DiseaseMovement Disorders+2 more
Novartis Pharmaceuticals 129
Large-scale testing (Phase 3)Study completedNCT01631825
What this trial is testing

A Long-Term Extension Trial From of SPM 962 in Advanced Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease
Otsuka Pharmaceutical Co., Ltd. 321
Testing effectiveness (Phase 2)Study completedNCT03541356
What this trial is testing

Therapeutic Potential for Intranasal Levodopa in Parkinson's Disease -Off Reversal

Who this might be right for
Parkinson's Disease
Impel Pharmaceuticals 32
Large-scale testing (Phase 3)Study completedNCT00823836
What this trial is testing

Clinical Evaluation of Ropinirole Prolonged Release/Extended Release (PR/XR) Tablet for Adjunctive Therapy to L-dopa in Subjects With Advanced Parkinson's Disease

Who this might be right for
Parkinson Disease
GlaxoSmithKline 302
Early research (Phase 1)Study completedNCT03754062
What this trial is testing

Pharmacological Modulation of Belief Salience

Who this might be right for
HaloperidolPlaceboL-DOPA
King's College London 30
Large-scale testing (Phase 3)Study completedNCT00004733
What this trial is testing

Timing of Levodopa Treatment in Parkinson's Disease

Who this might be right for
Parkinson's Disease
National Institute of Neurological Disorders and Stroke (NINDS)
Testing effectiveness (Phase 2)Study completedNCT00582673
What this trial is testing

Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients, and Safety in Combination With L-dopa

Who this might be right for
Parkinson's Disease
Novartis 31
Not applicableStudy completedNCT00552474
What this trial is testing

Deep Brain Stimulation to Treat Symptoms of Parkinson's Disease

Who this might be right for
Parkinson DiseaseMovement Disorders
Abbott Medical Devices 136
Load More Results